![](/img/cover-not-exists.png)
Asymmetric dimethylarginine (ADMA) as a prospective marker of cardiovascular disease and mortality—An update on patient populations with a wide range of cardiovascular risk
Rainer H. Böger, Renke Maas, Friedrich Schulze, Edzard SchwedhelmVolume:
60
Year:
2009
Language:
english
DOI:
10.1016/j.phrs.2009.07.001
File:
PDF, 382 KB
english, 2009